Status:
ACTIVE_NOT_RECRUITING
Whole-body Diffusion-weighted Magnetic Resonance Imaging for Staging and Treatment Prediction of Lymphoma
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Conditions:
Lymphoma
Hodgkin Lymphoma
Eligibility:
All Genders
Phase:
NA
Brief Summary
Whole body diffusion-weighted imaging is a functional magnetic resonance imaging technique that characterizes tissue by probing changes in water diffusion secondary to differences in the tissue micros...
Eligibility Criteria
Inclusion
- every patient with a new diagnosis of Hodgkin or Non-Hodgkin Lymphoma (only diffuse large B-cel lymphoma, mantle cell lymphoma, follicular lymphoma and PTLD)
Exclusion
- patient with general contraindications for MRI (pacemaker, claustrophobia, etc.)
- patients with a type of lymphoma other than those described in the inclusion criteria
Key Trial Info
Start Date :
November 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01231269
Start Date
November 1 2010
End Date
December 1 2025
Last Update
July 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Leuven
Leuven, Vlaams-Brabant, Belgium, 3000